Publication Name	World Journal of Gastroenterology
Manuscript ID	6393
Country	Italy

Received	2013-10-16 11:23
Peer-Review Started	2013-10-16 17:15
First Decision by Editorial Office Director
Return for Revision	2014-03-20 08:39
Revised	2014-03-27 00:49
Publication Fee Transferred
Second Decision by Editor	2014-06-05 10:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-06-05 11:08
Articles in Press	2014-06-05 11:21
Edit the Manuscript by Language Editor	2014-06-16 16:39
Typeset the Manuscript	2014-07-10 17:53
Publish the Manuscript Online	2014-07-26 13:36

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Hepatitis C virus reinfection after liver transplantation: Is there a role for direct antiviral agents?
Manuscript Source	Invited Manuscript
All Author List	Marco Dall’Agata, Annagiulia Gramenzi, Maurizio Biselli and Mauro Bernardi
Funding Agency and Grant Number
Corresponding Author	Mauro Bernardi, MD, Professor, Director, Semeiotica Medica - Policlinico S. Orsola-Malpighi, Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, Via Albertoni 15, 40138 Bologna, Italy. mauro.bernardi@unibo.it
Key Words	Hepatitis C virus; Liver transplantation; Direct antiviral agents; Peginterferon/ribavirin; Immunosuppressive agents
Core Tip	Considering the increasing shortage of donor organs and the accelerated progression of hepatitis C (HCV) in liver transplant recipients, the development of effective strategies to treat HCV recurrence are of paramount importance. The new classes of direct antiviral agents (DAAs) improved the results of antiviral therapy in HCV-infected immunocompetent patients. The aim of this review was to identify and summarize the potential benefit of DAAs in the liver transplant setting.
Publish Date	2014-07-26 13:36
Citation	Dall’Agata M, Gramenzi A, Biselli M, Bernardi M. Hepatitis C virus reinfection after liver transplantation: Is there a role for direct antiviral agents? World J Gastroenterol 2014; 20(28): 9253-9260
URL	http://www.wjgnet.com/1007-9327/full/v20/i28/9253.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i28.9253

Full Article (PDF)	WJG-20-9253.pdf
Full Article (Word)	WJG-20-9253.doc
Manuscript File	6393-Review.doc
Answering Reviewers	6393-Answering reviewers.pdf
Copyright License Agreement	6393-Copyright assignment.pdf
Peer-review Report	6393-Peer review(s).pdf
Scientific Misconduct Check	6393-CrossCheck.jpg
Scientific Editor Work List	6393-Scientific editor work list.pdf